Literature DB >> 679430

Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.

J Morganroth, E L Michelson, L N Horowitz, M E Josephson, A S Pearlman, W B Dunkman.   

Abstract

Variations in the frequency of ventricular premature depolarizations (VPDs) were evaluated with three consecutive 24-hour long-term electrocardiography monitor recordings from 15 clinically stable patients with various cardiac disorders. Mean hourly VPD frequencies ranged from 37--1,801 per hour. Data were subjected to 4 and 5 factor nested analyses of variance. The extent of spontaneous variation in arrhythmia frequency that occurred in individual patients from day to day was 23%, between 8-hour periods within days was 29%, and from hour to hour was 48%. In addition, the variability between repeated three-day monitoring periods over time was quantified in five patients and found to be 37%. This analysis determined that to distinguish a reduction in VPD frequency attributable to therapeutic intervention rather than biologic or spontaneous variation alone required a greater than 83% reduction in VPD frequency if only two-24-hour monitoring periods were compared, and greater than 65% reduction if two 72-hour periods were compared. The limitations of routine 24-hour electrocardiographic monitoring must be considered in diagnostic and therapeutic decision-making.

Entities:  

Mesh:

Year:  1978        PMID: 679430     DOI: 10.1161/01.cir.58.3.408

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  41 in total

1.  Slow [Na]i Changes and Positive Feedback Between Membrane Potential and [Ca]i Underlie Intermittent Early Afterdepolarizations and Arrhythmias.

Authors:  Yuanfang Xie; Zhandi Liao; Eleonora Grandi; Yohannes Shiferaw; Donald M Bers
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-09-25

Review 2.  Determination of antiarrhythmic drug efficacy in the treatment of ventricular arrhythmias.

Authors:  J Morganroth
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

3.  Antiarrhythmic efficacy of propafenone: evaluation of effective plasma levels following single and multiple doses.

Authors:  L Frabetti; B Marchesini; A Capucci; C Cavallini; S Gubelli; E Ambrosioni; B Magnani
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  [Treatment with mexiletine. Clinical and pharmacokinetic studies].

Authors:  H Breithaupt; A Schmidt
Journal:  Klin Wochenschr       Date:  1988-06-01

5.  Combined anti-arrhythmic therapy with class 1 and class 3 drugs.

Authors:  M A James; P Papouchado; J V Jones
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

6.  Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease.

Authors:  D E Stewart; H Ikram; E A Espiner; M G Nicholls
Journal:  Br Heart J       Date:  1985-09

Review 7.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

8.  Cardiac arrhythmias 48 hours before, during, and 48 hours after discharge from hospital following acute myocardial infarction.

Authors:  G W Morrison; E B Kumar; R W Portal; C P Aber
Journal:  Br Heart J       Date:  1981-05

9.  The effects of chronic oral cimetidine therapy on the cardiovascular system in man.

Authors:  S Saltissi; A Crowther; C Byrne; D J Coltart
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

Review 10.  Tocainide. A review of its pharmacological properties and therapeutic efficacy.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.